Overview

Efficacy and Safety of Ciprofol Compared to Propofol for Nonintubated General Anesthesia in Patients Undergoing TAVR

Status:
Not yet recruiting

Trial end date:
2022-02-04

Target enrollment:

Participant gender:

Summary

The purpose of this study is to explore the efficacy and safety of ciprofol compared to propofol for non-intubated general anesthesia in patients undergoing transcatheter aortic valve replacement (TAVR).

Phase:

Phase 4

Details

Lead Sponsor:

Haisco Pharmaceutical Group Co., Ltd.

Treatments:

Propofol